Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy

Austin Kulasekararaj, MBBS MDMRCP FRCPath, Antonio M. Risitano, MD PhD, Jaroslaw P. Maciejewski, MD PhD, Rosario Notaro, MD, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Jong-Wook Lee, MD, Mingjun Huang, PhD, Michael Geffner, MD, Robert A. Brodsky, MD

Blood (2019) 134 (Supplement_1): 3514.

https://doi.org/10.1182/blood-2019-124748

Published: 2019

Journal Articles

Dramatic Resolution of HLH after Treatment with the JAK 1/2 Inhibitor, Ruxolitinib

Scott R. Goldsmith, MD, Sana Saif Ur Rehman, MD, Cara Lunn Shirai, PhD, Ravi Vij, MBBS, John F. DiPersio, MD PhD

Blood (2019) 134 (Supplement_1): 2325.

https://doi.org/10.1182/blood-2019-124176

Published: 2019

Journal Articles

Biomarkers of Cardiopulmonary, Renal, and Liver Dysfunction in an Adult Sickle Cell Disease Cohort

Xu Zhang, PhD, Binal N. Shah, Roberto Machado, MD, Santosh L. Saraf, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3574.

https://doi.org/10.1182/blood-2019-131813

Published: 2019

Journal Articles

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621

Maureen M O'Brien, MD, Lingyun Ji, PhD, Nirali N. Shah, MD, Susan R. Rheingold, MD, Deepa Bhojwani, MD, Joanna S. Yi, MD, Constance M. Yuan, MD PhD, Andrew C Harris, MD, Patrick A. Brown, MD, Michael J. Borowitz, MD PhD, Olga Militano, PharmD, Meenakshi Devidas, PhD, Elizabeth A. Raetz, MD, Lia Gore, MD, Mignon L. Loh, MD

Blood (2019) 134 (Supplement_1): 741.

https://doi.org/10.1182/blood-2019-128977

Published: 2019

Journal Articles

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

Joanna S. Yi, MD, Tiffany Chambers, MPH, Kelly D Getz, Tamara P. Miller, MDMSc, Evanette Burrows, MPH, Marla Daves, MD, Philip J. Lupo, PhD MPH, Michael E. Scheurer, PhD MPH, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, Maria Monica J. Gramatges, MD PhD

Blood (2019) 134 (Supplement_1): 3814.

https://doi.org/10.1182/blood-2019-123992

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Ashley Thrower, BS, Zhou Laura, Vimal K. Derebail, MD, David Wichlan, Ashley Smith, RN, Jianwen Cai, PhD, Kenneth I. Ataga, MD

Blood (2019) 134 (Supplement_1): 2308.

https://doi.org/10.1182/blood-2019-131368

Published: 2019

Journal Articles

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Mustafa Saudi, MD

Blood (2018) 132 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2018-99-117765

Published: 2018

Journal Articles

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Paul C Williams, MD, Ileana Lopez-Plaza, MD

Blood (2018) 132 (Supplement 1): 5075.

https://doi.org/10.1182/blood-2018-99-111196

Published: 2018

Journal Articles

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Joanna S. Yi, MD, Tiffany Simone Chambers, BS, Kelly D Getz, PhD, Michael Scheurer, MPH, PhD, Philip J Lupo, PhD, Evanette Burrows, MPH, Marla Daves, MD, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, M. Monica Gramatges, MD PhD

Blood (2018) 132 (Supplement 1): 1383.

https://doi.org/10.1182/blood-2018-99-115691

Published: 2018

Journal Articles

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

Jesus C Fabregas, MD, Guiset Carvajal, MD

Blood (2018) 132 (Supplement 1): 4963.

https://doi.org/10.1182/blood-2018-99-112029

Published: 2018

Journal Articles

Hepatic Complications in Children with Sickle Cell Anemia Are Rare but Potentially Lethal

Mariane De Montalembert, MD PhD, Slimane Allali, MD, Laurent Dupic, MD, Cecile Dumesnil, MD, Annie Kamden, MD, Vincent Gajdos, MD PhD, Audrey Coilly, MD, Christophe Chardot, MD PhD, Martin Chalumeau, MD PhD, Valentine Brousse, MD, Florence Lacaille, MD

Blood (2017) 130 (Supplement 1): 4786.

https://doi.org/10.1182/blood.V130.Suppl_1.4786.4786

Published: 2017

Journal Articles

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Ahmet Yalcinkaya, MD, Selma Unal, MD, Yesim Oztas, MD PhD

Blood (2017) 130 (Supplement 1): 2240.

https://doi.org/10.1182/blood.V130.Suppl_1.2240.2240

Published: 2017

Journal Articles

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Andres Forero-Torres, MD, Seth Rosen, MD, David C. Smith, MD, Glenn Lesser, MD, Julio Peguero, MD, Shilpa Gupta, MD, Justin M. Watts, MD, Marcus Noel, MD, Razelle Kurzrock, MD, Haeseong Park, MD, Patricia LoRusso, DO, Catherine C. Coombs, MD, Fred Zheng, MD, Julie Switzky, RN, Swamy Yeleswaram, PhD, Gerald Falchook, MD

Blood (2017) 130 (Supplement 1): 4048.

https://doi.org/10.1182/blood.V130.Suppl_1.4048.4048

Published: 2017

Journal Articles

Characteristics of a Chronic Pain Phenotype in Adults with Sickle Cell Disease

James G. Taylor, MD, Kathleen Vaughan, BA, Lena Diaw, PhD, Caterina Minniti, MD, Inna Belfer, MDPhD

Blood (2017) 130 (Supplement 1): 3555.

https://doi.org/10.1182/blood.V130.Suppl_1.3555.3555

Published: 2017

Journal Articles

Laboratorial and Genetic Biomarkers Associated to Cerebral Blood Flow Velocity on Hemoglobin SC Disease

Rayra Pereira Santiago, MSc, Camilo Vieira, MSc, MD, Corynne Stephanie Ahouefa Adanho, MSc, Sanzio Silva Santana, MSc, Caroline Conceição Guarda, MSc, Camylla Vilas Boas Figueiredo, Graduated, Luciana Magalhaes Fiuza, Graduation student, Thassila Nogueira Pitanga, PhD, Junia Raquel Dutra Ferreira, MSc, Milena Magalhães Aleluia, MSc, Rodrigo Oliveira Mota, Msc, Dalila Luciola Zanette, PhD, Isa Menezes Lyra, MD PhD, Marilda Souza Goncalves, PhD

Blood (2016) 128 (22): 4847.

https://doi.org/10.1182/blood.V128.22.4847.4847

Published: 2016

Journal Articles

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Serge Pissard, MD PhD, Adrien Pecriaux, Catherine Paillard, MD PhD, Anne Galoisy, PharmD, Jean Riou, Nathalie Le Metayer, Henri Wajcman, MD PhD

Blood (2016) 128 (22): 4850.

https://doi.org/10.1182/blood.V128.22.4850.4850

Published: 2016

Journal Articles

Acute Chest Syndrome Rate at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Fuad El Rassi, MD, Eldrida Randall, MS, Sidney F. Stein, MD, H. Jean Khoury, MD, James R. Eckman, MD, Morgan L. McLemore, MD

Blood (2015) 126 (23): 3420.

https://doi.org/10.1182/blood.V126.23.3420.3420

Published: 2015

Journal Articles

Splenic Infarction Induced By Epstein-Barr Virus Infection in a Patient with Sickle Cell Trait

Rofida Nofal, MD, Hadi Sawaf, MD, Lida Zeinali, MD

Blood (2015) 126 (23): 4600.

https://doi.org/10.1182/blood.V126.23.4600.4600

Published: 2015

Journal Articles

Alemtuzumab for Treatment of Refractory Evans Syndrome

Timothy O'Brien, MD

Blood (2015) 126 (23): 4542.

https://doi.org/10.1182/blood.V126.23.4542.4542

Published: 2015

NARROW

A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy

Dramatic Resolution of HLH after Treatment with the JAK 1/2 Inhibitor, Ruxolitinib

Biomarkers of Cardiopulmonary, Renal, and Liver Dysfunction in an Adult Sickle Cell Disease Cohort

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission

Hepatic Complications in Children with Sickle Cell Anemia Are Rare but Potentially Lethal

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Characteristics of a Chronic Pain Phenotype in Adults with Sickle Cell Disease

Laboratorial and Genetic Biomarkers Associated to Cerebral Blood Flow Velocity on Hemoglobin SC Disease

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Acute Chest Syndrome Rate at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Splenic Infarction Induced By Epstein-Barr Virus Infection in a Patient with Sickle Cell Trait

Alemtuzumab for Treatment of Refractory Evans Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only